- Home
- DERM vs OXSQ Comparison
DERM vs OXSQ Comparison
Compare DERM & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- OXSQ
- Stock Information
- Founded
- DERM 2014
- OXSQ 2003
- Country
- DERM United States
- OXSQ United States
- Employees
- DERM N/A
- OXSQ N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- OXSQ Blank Checks
- Sector
- DERM Health Care
- OXSQ Finance
- Exchange
- DERM Nasdaq
- OXSQ Nasdaq
- Market Cap
- DERM 181.0M
- OXSQ 164.9M
- IPO Year
- DERM 2021
- OXSQ N/A
- Fundamental
- Price
- DERM $6.28
- OXSQ $2.21
- Analyst Decision
- DERM Strong Buy
- OXSQ
- Analyst Count
- DERM 2
- OXSQ 0
- Target Price
- DERM $10.00
- OXSQ N/A
- AVG Volume (30 Days)
- DERM 97.5K
- OXSQ 567.4K
- Earning Date
- DERM 08-11-2025
- OXSQ 08-12-2025
- Dividend Yield
- DERM N/A
- OXSQ 19.05%
- EPS Growth
- DERM N/A
- OXSQ N/A
- EPS
- DERM N/A
- OXSQ N/A
- Revenue
- DERM $56,243,000.00
- OXSQ $42,166,831.00
- Revenue This Year
- DERM $28.99
- OXSQ N/A
- Revenue Next Year
- DERM $52.61
- OXSQ N/A
- P/E Ratio
- DERM N/A
- OXSQ N/A
- Revenue Growth
- DERM N/A
- OXSQ N/A
- 52 Week Low
- DERM $3.54
- OXSQ $2.19
- 52 Week High
- DERM $8.25
- OXSQ $3.10
- Technical
- Relative Strength Index (RSI)
- DERM 38.72
- OXSQ 22.78
- Support Level
- DERM $6.29
- OXSQ $2.26
- Resistance Level
- DERM $7.13
- OXSQ $2.33
- Average True Range (ATR)
- DERM 0.41
- OXSQ 0.03
- MACD
- DERM -0.15
- OXSQ -0.00
- Stochastic Oscillator
- DERM 3.31
- OXSQ 13.33
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.